Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
editorial
. 2009 May 18;32(5):288. doi: 10.1002/clc.20464

Clinical Implications of Elevated Serum Interleukin‐6, Soluble CD40 Ligand, Metalloproteinase‐9, and Tissue Inhibitor of Metalloproteinase‐1 in Patients with Acute ST‐segment Elevation Myocardial Infarction

Alberto Dominguez‐Rodriguez 1,, Pedro Abreu‐Gonzalez 2
PMCID: PMC6653739  PMID: 19452490

Full Text

The Full Text of this article is available as a PDF (42.5 KB).

References

  • 1. Tan J, Hua Q, Gao J, Fan ZX: Clinical implications of elevated serum interleukin‐6, soluble CD40 ligand, metalloproteinase‐9 and tissue inhibitor of metalloproteinase‐1 in patients with acute ST‐segment elevation myocardial infarction. Clin Cardiol 2008; 31: 413–418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA: Increased risk of congestive heart failure among infarctions with nighttime onset. Am Heart J 2000; 140: 438–442. [DOI] [PubMed] [Google Scholar]
  • 3. Muller JE, Tofler GH, Stone PH: Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733–743. [DOI] [PubMed] [Google Scholar]
  • 4. Jankovic BD: Neuroimmunomodulation. From phenomenology to molecular evidence. Ann NY Acad Sci 1994; 741: 1–38. [PubMed] [Google Scholar]
  • 5. Dominguez‐Rodriguez A, Abreu‐Gonzalez P, Garcia M, Ferrer J, de la Rosa A, et al: Light/dark patterns of interleukin‐6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26: 89–93. [DOI] [PubMed] [Google Scholar]
  • 6. Dominguez‐Rodriguez A, Garcia‐Gonzalez M, Abreu‐Gonzalez P, Ferrer J, Kaski JC: Relation of nocturnal melatonin levels to C‐reactive protein concentration in patients with ST‐segment elevation myocardial infarction. Am J Cardiol 2006; 97: 10–12. [DOI] [PubMed] [Google Scholar]
  • 7. Dominguez‐Rodriguez A, Abreu‐Gonzalez P, Garcia‐Gonzalez MJ, Reiter RJ: Relation of nocturnal melatonin levels to serum matrix metalloproteinase‐9 concentrations in patients with myocardial infarction. Thromb Res 2007; 120: 361–366. [DOI] [PubMed] [Google Scholar]
  • 8. Dominguez‐Rodriguez A, Abreu‐Gonzalez P, Garcia‐Gonzalez MJ, Samimi‐Fard S, Kaski JC, et al.: Light/dark patterns of soluble vascular cell adhesion molecule‐1 in relation to melatonin in patients with ST‐segment elevation myocardial infarction. J Pineal Res 2008; 44: 65–69. [DOI] [PubMed] [Google Scholar]
  • 9. Dominguez‐Rodriguez A, Abreu‐Gonzalez P, Garcia‐Gonzalez MJ, Kaski JC: Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation. Thromb Res 2008; Doi:10.9016/jthromres.2008.05.006. [DOI] [PubMed] [Google Scholar]
  • 10. Rudnicka AR, Rumley A, Lowe GD, Strachan DP: Diurnal, seasonal, and blood‐processing patterns in levels of circulating fibrinogen, fibrin D‐dimer, C‐reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45‐year‐old population. Circulation 2007; 115: 996–1003. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES